Clinical Trial: Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects

U.S., Feb. 4 -- ClinicalTrials.gov registry received information related to the study (NCT07384104) titled 'Compare the Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of SAL023 and Italy-Manufactured Evenity in Healthy Subjects' on Jan. 13.

Brief Summary: Primary objective of this study is to evaluate the similarity in pharmacokinetic characteristics between SAL023 Injection and Italy-manufactured Evenity. Secondary objective is to assess the similarity in safety, pharmacodynamic and immunogenicity profiles of SAL023 Injection and Italy-manufactured Evenity.

Study Start Date: Oct. 19, 2025

Study Type: INTERVENTIONAL

Condition: Osteoporosis

Intervention: DRUG: SAL0123

Dosage Form: Injection Specification: 105mg:1.17ml ...